auto_awesome
Want to know who else bid on this?
Proposal Forge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Recipient
Ottawa Hospital Research InstituteDepartment
National Research Council CanadaAmount
$217.9K
Province
ONType
C
Agreement Number
986038
Purpose
This project will support the development, validation, qualification and execution of a number of release assays critical to the release of the GMP lentiviral vector that will be used to generate a next generation CAR-T cell product (CD22) to be tested in a clinical trial extending across Canada. Manufacturing of the lentiviral product is scheduled to start February 2022.
Ottawa Hospital Research Institute × National Research Council Canada
13 grants totalling $7.0M
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
1,000 grants totalling $348.9M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| University of Ottawa | $3.6M | Collaborative Science, Technology and In... |
| University of Ottawa | $3.6M | Collaborative Science, Technology and In... |
| University of Ottawa | $3.6M | Collaborative Science, Technology and In... |
| University of Ottawa | $3.6M | Collaborative Science, Technology and In... |
| The Governing Council of the University of Toronto | $3.0M | Collaborative Science, Technology and In... |